L. Patrick Gage, PhD
Scientific Advisory Board
Pat Gage has served in numerous positions of leadership in the pharmaceutical and biotech industry since 1971. During 18 years at Hoffmann-La Roche he advanced from the Institute of Molecular Biology to V.P., Exploratory Research (Discovery Research for the US). In 1989 he joined Genetics Institute, Inc. -- first as R&D head, and then President in 1997 after Wyeth (now Pfizer) acquired the company. In 1998, Pat was named President of Wyeth Research, taking responsibility for global pharmaceutical and vaccine R&D of Wyeth and Genetics Institute, and in 2000 was also named SVP, Science and Technology for Wyeth. At that time he was also tasked with responsibility for global biopharmaceutical manufacturing, continuing to build a major component of the Wyeth pharmaceutical enterprise. During his career at Roche, GI and Wyeth, he oversaw the development of more than a dozen marketed biologics, as well as several small molecule drugs.
In addition to serving in an advisory capacity and on biotech company boards, he serves as Chairman of Cytokinetics, Inc (Nasdaq: CYTK) and Chairman of Tetraphase Pharmaceuticals. Pat is also a Trustee of the Marine Biological Laboratories, Woods Hole, MA. He previously was Chairman and subsequently Interim CEO of PDL BioPharma (Nasdaq: PDLI), and was Chairman of Adnexus Therapeutics. Pat founded enGage Biotech Consulting in 2003 to focus on guiding the development of new biopharmaceutical products and companies.